Tus kws kho mob
QP54-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2023
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1981 - 1990 ntawm 4179
Tus kws kho mob
QP55-23 Change in Processing for Replacement Claims
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023
Cov Txiaj Ntsig thiab Kev Duav Roos
2023 Blue Cross Dental Plans Individual and Family Plan Rates
Tus kws kho mob
P46-23 Services Removed from the Commercial Prior Authorization List
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P23R1-23 Laboratory Services: Lab Rebundling Reimbursement Policy will not be Updated
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2023
Cov Txiaj Ntsig thiab Kev Duav Roos
2025 Individual and Family Dental Preferred Plan
Cov Txiaj Ntsig thiab Kev Duav Roos
2025 Individual and Family Blue Cross Dental Value Plans
Tus kws kho mob
P54-24 Changes to the Medication Therapy Management (MTM) Program, Effective January 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tus kws kho mob
P57-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tus kws kho mob
2024 September Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024